Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.27B | 1.37B | 1.37B | 1.14B | 1.14B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.27B | 1.37B | 1.37B | 1.14B | 1.14B |
| Cost of Revenue | 545.00M | 570.00M | 586.00M | 555.00M | 530.00M |
| Gross Profit | 720.00M | 798.00M | 785.00M | 589.00M | 607.00M |
| SG&A Expenses | 393.00M | 449.00M | 381.00M | 331.00M | 351.00M |
| Depreciation & Amortization | 144.00M | 139.00M | 138.00M | 139.00M | 140.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.18B | 1.25B | 1.20B | 1.12B | 1.11B |
| Operating Income | 84.00M | 118.00M | 169.00M | 26.00M | 27.00M |
| Income Before Tax | 24.00M | 56.00M | 87.00M | -259.00M | -50.00M |
| Income Tax Expenses | 6.00M | 2.00M | 30.00M | 17.00M | -16.00M |
| Earnings from Continuing Operations | 18.00M | 54.00M | 57.00M | -276.00M | -34.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.00M | 54.00M | 57.00M | -276.00M | -34.00M |
| EBIT | 84.00M | 118.00M | 169.00M | 26.00M | 27.00M |
| EBITDA | 255.00M | 283.00M | 335.00M | 194.00M | 195.00M |
| EPS Basic | 0.04 | 0.11 | 0.11 | -0.56 | -0.07 |
| Normalized Basic EPS | 0.03 | 0.08 | 0.13 | -0.05 | -0.03 |
| EPS Diluted | 0.04 | 0.11 | 0.11 | -0.56 | -0.07 |
| Normalized Diluted EPS | 0.03 | 0.08 | 0.13 | -0.05 | -0.03 |
| Average Basic Shares Outstanding | 499.70M | 499.50M | 497.70M | 496.90M | 496.80M |
| Average Diluted Shares Outstanding | 506.50M | 505.90M | 506.00M | 496.90M | 496.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |